These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35188622)

  • 21. Comparison and clinical analysis of antibiotics and endoscopic injection for vesicoureteral reflux in children.
    Yang Z; Dai K; Sun X; Tian C; Yuan L; Liu J; Li B; Chung PHY; Wong KKY
    Pediatr Surg Int; 2024 Jul; 40(1):184. PubMed ID: 38995440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of endoscopic treatment in vesicoureteral reflux after kidney transplantation.
    Tadrist A; Morelli M; Gondran-Tellier B; Akiki A; McManus R; Delaporte V; Bastide C; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    World J Urol; 2022 Mar; 40(3):815-821. PubMed ID: 35028772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
    Ozok U; Eroglu M; Imamoglu A; Bakirtaş H; Güvence N; Kiper A
    J Endourol; 2005 Dec; 19(10):1185-7. PubMed ID: 16359211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter?
    Yucel S; Akin Y; Celik O; Erdogru T; Baykara M
    J Endourol; 2010 Oct; 24(10):1661-4. PubMed ID: 20626270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux.
    Tekin A; Yagmur I; Tiryaki S; Dokumcu Z; Ulman I; Avanoglu A
    Int Braz J Urol; 2018; 44(6):1194-1199. PubMed ID: 30325612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization.
    Zambaiti E; Sergio M; Di Pace MR; Casuccio A; Cimador M
    J Pediatr Urol; 2020 Apr; 16(2):191.e1-191.e6. PubMed ID: 31928899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of novel STING bulking agents.
    Starmer B; McAndrew F; Corbett H
    J Pediatr Urol; 2019 Oct; 15(5):484-490. PubMed ID: 31591047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
    Cloutier J; Blais AS; Moore K; Bolduc S
    J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.
    Sheth KR; White JT; Stanasel I; Janzen N; Mittal A; Koh CJ; Austin PF; Roth DR; Tu DD; Gonzales ET; Ryan S; Jorgez C; Seth A
    J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reflux Timing Is a Predictor of Successful Endoscopic Treatment of Vesicoureteral Reflux.
    Han DS; Cambareri G; Alagiri M; Chiang G
    Urology; 2019 Feb; 124():237-240. PubMed ID: 30385258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy.
    Lee JN; Lee SM; Ha YS; Kim BS; Kim HT; Kim TH; Yoo ES; Kwon TG; Chung SK
    J Pediatr Urol; 2016 Aug; 12(4):255.e1-6. PubMed ID: 27220472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic treatment of symptomatic VUR disease after the renal transplantation: analysis of 49 cases.
    Balaban M; Ozkaptan O; Cubuk A; Sahan A; Duzenli M; Tuncer M
    Clin Exp Nephrol; 2020 May; 24(5):483-488. PubMed ID: 31955313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B; Mele E; Kocherov S; Zilber S; Gerocarni Nappo S; Capozza N
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic treatment for vesicoureteral reflux: how important is technique?
    Watters ST; Sung J; Skoog SJ
    J Pediatr Urol; 2013 Dec; 9(6 Pt B):1192-7. PubMed ID: 23769202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
    Kirsch AJ; Perez-Brayfield MR; Scherz HC
    J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux.
    Baydilli N; Selvi I; Pinarbasi AS; Akinsal EC; Demirturk HC; Tosun H; Demirci D
    J Pediatr Urol; 2021 Feb; 17(1):68.e1-68.e8. PubMed ID: 33272864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reliability of VCUG performed within 24 hours after injection of dextranomer/hyaluronic acid in patients with vesico-ureteral reflux.
    Oh MM; Park MG; Kim JW; Yoo KH; Lee JW; Yoon CY; Park HS; Moon du G
    Urology; 2014 Jan; 83(1):191-4. PubMed ID: 24041674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the endoscopic treatment of primary vesicoureteral reflux.
    Akin M; Erginel B; Karadag CA; Yildiz A; Ozçelik GS; Sever N; Genc NM; Dokucu AI
    Int Urol Nephrol; 2014 Nov; 46(11):2057-61. PubMed ID: 24966099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can distal ureteral diameter measurement predict primary vesicoureteral reflux clinical outcome and success of endoscopic injection?
    Payza AD; Hoşgör M; Serdaroğlu E; Sencan A
    J Pediatr Urol; 2019 Oct; 15(5):515.e1-515.e8. PubMed ID: 31420285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure.
    Elmore JM; Scherz HC; Kirsch AJ
    J Urol; 2006 Feb; 175(2):712-5. PubMed ID: 16407036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.